Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
Completed · Phase 3
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known if paclitaxel is more effective with or without gemcitabine for advanced breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel with or without gemcitabine in treating women who have advanced breast cancer.
Key facts
- Study ID
- NCT00006459
- Run by
- Eli Lilly and Company
- Starts
- 2000-07-01
- Expected to finish
- 2005-10-01
- Last updated by the study team
- 2012-06-07
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Comprehensive Cancer Institute of Huntsville — Huntsville, Alabama, United States
- Little Rock Hematology-Oncology Associates — Little Rock, Arkansas, United States
- Pacific Coast Hematology/Oncology Medical Group — Fountain Valley, California, United States
- Office of Alex J.P. Makalinao — Los Angeles, California, United States
- Hematology/Oncology Group — Santa Rosa, California, United States
- University of Colorado Cancer Center — Denver, Colorado, United States
- Danbury Internal Medicine — Danbury, Connecticut, United States
- Comprehensive Cancer Care Specialists of Boca Raton — Boca Raton, Florida, United States
- Mercy Hospital — Miami, Florida, United States
- Mountain States Tumor Institute — Boise, Idaho, United States
- Memorial Medical Center — Springfield, Illinois, United States
- Carle Cancer Center — Urbana, Illinois, United States
- Indiana Community Cancer Care, Inc. — Indianapolis, Indiana, United States
- Cancer Health Associates — Michigan City, Indiana, United States
- North Mississippi Hematology and Oncology Associates, Ltd. — Tupelo, Mississippi, United States
- St. John's Mercy Medical Center — St Louis, Missouri, United States
- APN-IMPATH Research Corporation — Fort Lee, New Jersey, United States
- Overlook Hospital — Summit, New Jersey, United States
- HemOnCare, P.C. — Brooklyn, New York, United States
- Interlakes Oncology/Hematology PC — Rochester, New York, United States
- N.W. Carolina Oncology & Hematology, P.A. — Hickory, North Carolina, United States
- Oklahoma Oncology Inc. — Tulsa, Oklahoma, United States
- Rittenhouse Hematology/Oncology — Philadelphia, Pennsylvania, United States
- South Carolina Oncology Associates — Columbia, South Carolina, United States
- Office Of C. Michael Jones — Germantown, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.